Riskpilot← Back to searchSign inGet full accessPharmados Oy
OYActiveY-tunnus 2526679-6Teknologiantie 14-FRetail sale of medical and orthopaedic goods · NACE 4774Est. 201363 employees
Revenue 2025
EUR 1,3B
+10737% vs 2024
EBITDA margin
3.2%
+10660% vs 2024
Equity ratio
50.1%
Financial strength
Net profit 2025
EUR 33M
+8752% vs 2024
| Revenue | EUR 1,3B | +10737% |
| EBITDA | EUR 43,4M | +10660% |
| Net profit | EUR 33M | +8752% |
| Total assets | EUR 1,8M | +13% |
| Equity | EUR 892K | +44% |
| Employees | 63 | — |
Legal name
Pharmados Oy
Y-tunnus number
2526679-6
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
23. tammikuuta 2013
Share capital
EUR 16 700
Employees
63 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on apteekki-, terveys-, lääke- ja kaupan alan konsultointi-, markkinointi-, valmistus- ja asiantuntijapalvelut ja niihin liittyvä kehittämistoiminta sekä terveystuotteiden, ravintolisien ja lääkkeiden maahantuonti, maastavienti, edustus, tukku- ja vähittäiskauppa. Yhtiön toimialaan kuuluu lisäksi alkoholijuomien ja valmisteiden maahantuonti ja kauppa. Yhtiö voi tuottaa farmaseuttisia erikoispalveluita kuten henkilöstön vuokraus-, telemarkkinointi- ja sähköisiä palveluita. Yritys voi vuokrata, omistaa ja hallita liiketiloja, kalusteita ja tarvikkeita. Yritys voi myös omistaa kiinteistöjä, arvopapereita tai muuta omaisuutta.
Address
Teknologiantie 14-F
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 308 | 7 124 | 8 211 | 12 320 | 1 335 133 |
| Staff expenses | −775 | −828 | −1 140 | −1 427 | −163 396 |
| EBITDA | 112 | 299 | −290 | 403 | 43 370 |
| Depreciation & amort. | −17 | −4 | −6 | −6 | −2 005 |
| EBIT | 95 | 295 | −297 | 397 | 41 365 |
| Net financials | −9 | −10 | −7 | −7 | −1 |
| Profit before tax | 86 | 285 | −304 | 390 | 41 255 |
| Tax | 17 | 57 | −0 | 17 | 82 |
| Net profit | 68 | 228 | −304 | 373 | 33 009 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 053 | 1 186 | 1 186 | 1 578 | 1 781 |
| Equity | 323 | 728 | 551 | 620 | 892 |
| Long-term debt | 232 | — | 176 | 75 | 0 |
| Short-term debt | 498 | 458 | 612 | 883 | 889 |
| Total debt | 730 | 458 | 788 | 958 | 889 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20212025
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
3701.2%
This company
18.4%
Market median
+20015% vs market
20212025
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20212025
Asset turnover
749.63×
This company
1.12×
Market median
+66831% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MM Deputy auditor | Deputy auditor | 2025 |
EA Confidential Clerk | Confidential Clerk | 2024 |
JF Audit | Audit | 2017 |
KM Confidential Clerk | Confidential Clerk | 2024 |
| Former (2) | ||
AG Deputy auditor | Deputy auditor | 2017 – 2025 |
AK Confidential Clerk | Confidential Clerk | 2017 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2020 | |
| Chairperson | 2020 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2017 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmados Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Marianne Peräkorpi | Deputy auditor | 0 companies |
| Anders Gabriel Björk | Deputy auditor | 0 companies |
| Anja Kaarina Taube-Siikavirta | Confidential Clerk | 0 companies |
| Ella Amanda Ravaska | Confidential Clerk | 0 companies |
| Johan-Erik Fant | Audit | 0 companies |
| Katri Marjaana Erkkilä | Confidential Clerk | 0 companies |
| Pasi Ilmari Palmroos | Board of Directors | 0 companies |
| Petri Kullervo Kumlin | Chairperson | 0 companies |
| Kim Vilhelm Forsén | Board of Directors | 0 companies |
| Risto Tapani Holma | Board of Directors | 0 companies |
| Juha Antero Keskitalo | Board of Directors | 0 companies |
| Janne Henrik Leino | Board of Directors | 0 companies |